MENU
+Compare
VYGR
Stock ticker: NASDAQ
AS OF
Sep 3, 04:59 PM (EDT)
Price
$3.69
Change
+$0.11 (+3.07%)
Capitalization
198.58M

VYGR Voyager Therapeutics Forecast, Technical & Fundamental Analysis

Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases... Show more

Industry: #Biotechnology
VYGR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for VYGR with price predictions
Sep 02, 2025

Aroon Indicator for VYGR shows an upward move is likely

VYGR's Aroon Indicator triggered a bullish signal on August 04, 2025. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 100 similar instances where the Aroon Indicator showed a similar pattern. In of the 100 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

VYGR moved above its 50-day moving average on August 12, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where VYGR advanced for three days, in of 259 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on August 27, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on VYGR as a result. In of 88 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for VYGR turned negative on August 22, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 40 similar instances when the indicator turned negative. In of the 40 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where VYGR declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

VYGR broke above its upper Bollinger Band on August 13, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.813) is normal, around the industry mean (19.852). P/E Ratio (6.318) is within average values for comparable stocks, (51.814). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.136). Dividend Yield (0.000) settles around the average of (0.044) among similar stocks. P/S Ratio (4.895) is also within normal values, averaging (322.082).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. VYGR’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. VYGR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
VYGR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

VYGR is expected to report earnings to fall 8.63% to -52 cents per share on November 18

Voyager Therapeutics VYGR Stock Earnings Reports
Q3'25
Est.
$-0.52
Q2'25
Missed
by $0.04
Q1'25
Missed
by $0.08
Q4'24
Missed
by $0.22
Q3'24
Beat
by $0.29
The last earnings report on August 06 showed earnings per share of -56 cents, missing the estimate of -52 cents. With 403.93K shares outstanding, the current market capitalization sits at 198.58M.
A.I. Advisor
published General Information

General Information

a developer of gene therapies for fatal and debilitating diseases of the central nervous system

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
75 Hayden Avenue
Phone
+1 857 259-5340
Employees
162
Web
https://www.voyagertherapeutics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
COIHF33.85N/A
N/A
Croda International Plc
PTZIF11.33N/A
N/A
PATRIZIA SE
CGMBF0.58N/A
N/A
China Minsheng Banking Corp., Ltd.
MSTH0.01N/A
N/A
Mystic Holdings Inc.
CPNFF0.14N/A
-0.78%
Euro Sun Mining Inc.

VYGR and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, VYGR has been loosely correlated with RGNX. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if VYGR jumps, then RGNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VYGR
1D Price
Change %
VYGR100%
+6.55%
RGNX - VYGR
53%
Loosely correlated
+2.13%
KYMR - VYGR
51%
Loosely correlated
-1.24%
XNCR - VYGR
49%
Loosely correlated
+5.17%
TRDA - VYGR
49%
Loosely correlated
-1.65%
IDYA - VYGR
47%
Loosely correlated
+3.79%
More